Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
18 October, 2018 12:12 IST
Suven Life Sciences secures 2 overseas product patents
Source: IRIS | 17 May, 2018, 11.03AM
Comments  |  Post Comment

Suven Life Sciences announces today that the grant of two product patents from Australia and one product patent from Singapore corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2034.

The granted claims of the patents include the class of selective H3 Inverse agonists and 5HT6 compounds respectively and are being developed as therapeutic agents for major depressive disorders and for the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, Attention deficient hyperactivity disorder (ADHD), Huntington's disease, Narcolepsy, Parkinson and Schizophrenia respectively.

''We are very pleased by the grant of these patents to Suven for our pipeline of molecules in CNS arena that are being developed for cognitive disorders with high unmet medical need with huge market potential globally,'' says Venkat Jasti, CEO of Suven.

Shares of the company declined Rs 3.05, or 1.59%, to trade at Rs 188.65. The total volume of shares traded was 28,852 at the BSE (10.49 a.m., Thursday).





Suven Life Sciences Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Ramco Systems partners with Airbus Helicopters SAS - 18-Oct-2018 10:26
ABB bags transformer order worth Rs 1.15 bn from Indian Railways - 18-Oct-2018 10:20
Zydus Cadila gets nod for Clobetasol propionate cream - 17-Oct-2018 15:19
Aurionpro Solutions to acquire majority stake in Singapore based SC Soft - 17-Oct-2018 13:26
Adani Group partners with Total to provide multi-energy offering - 17-Oct-2018 13:16
Sterlite Tech wins Rs 35 bn contract for Indian Navy's digital network - 16-Oct-2018 11:03
Lupin receives tentative approval for generic Lurasidone HCl tablets - 16-Oct-2018 09:42
Glenmark Pharma gets nod for Hydrocortisone Valerate cream - 16-Oct-2018 09:25
Shriram Transport to raise upto Rs 13.50 bn via NCDs - 15-Oct-2018 10:29
Infosys completes acquisition of Fluido - 15-Oct-2018 10:25
Dr. Reddy's Lab sells Hyderabad API manufacturing unit - 15-Oct-2018 10:14
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer